Navigation Links
CoreLab Partners Opens Office in Tokyo, Japan

PRINCETON, N.J., Jan. 17, 2012 /PRNewswire/ -- Signaling a further commitment to expand its business model in the Pacific Rim and building a global presence as one of the largest imaging and cardiac safety core labs in the world, CoreLab Partners, Inc. today has announced the opening of an office in Tokyo, Japan under the wholly owned subsidiary of CoreLab Partners Japan, K.K.

"We are pleased to announce the creation of our new subsidiary in Asia corresponding with the opening of an office in central Tokyo," said CoreLab Partners' President and Chief Executive Officer, Dr. Mike Woehler. "This expanded presence is a natural extension of our geographic reach and global strategy to serve our growing base of multinational biopharma companies operating in the region and will complement our operational capability, which was established in Shanghai, China, over a decade ago," added Woehler.

CoreLab Partners currently has a strong business alliance in Japan with Suzuken Co. Ltd., which markets its cardiac safety services; this new presence is designed to further establish the global brand in the Pacific Rim and expand their full line of imaging sciences capabilities in Southeast Asia. "CoreLabs has been present in the region since 1999 and has conducted hundreds of drug development studies in both cardiac safety and imaging for a variety of sponsor partners. The addition of a local Regional Director and Business Development professional will allow CoreLab Partners to better service our client base by nurturing current relationships and opening up new markets for our full line of cardiac safety and imaging services," said Kevin Duffy, Vice President, Global Business Development.

About CoreLab Partners, Inc.

CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with board certified, sub-specialty trained Radiologists, Cardiologists, nuclear medicine physicians and Oncologists. CoreLab Partners delivers disciplined solutions for the collection, analysis and management of patient images and cardiac safety & efficacy information during drug development. Driven by best-in-class science, emerging technologies and service quality, CoreLabs is a global leader providing imaging sciences in all major modalities complemented by service offerings in the conduct of automated ECG, Thorough QT, Holter Monitoring, Ambulatory Blood Pressure Monitoring and Pulse Wave Analysis.

Kevin D. Duffy
Vice President, Global Business Development
Phone: 609-936-2600

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE CoreLab Partners, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CoreLab Partners Completes First TQT Study in Japan
2. CoreLab Partners Launches New DXA Imaging Service Offerings
3. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
4. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
5. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
6. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
7. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
8. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
9. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
10. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
11. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) Series ... Warrants") subject to the previously disclosed November 1, ... which will result in the issuance of 365,518 ... issuance of such shares, there will be approximately ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... are paramount. Insertion points for in-line sensors can represent a weak spot where ... InTrac 781/784 series of retractable sensor housings , which are designed to tolerate ...
(Date:11/24/2015)... Vancouver, BC (PRWEB) , ... November 24, 2015 ... ... to our customer, OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology ... Creation Technologies’ Texas facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device ...
(Date:11/24/2015)... ANGELES , Nov. 24, 2015 ... biotechnology company focused on the discovery, development and commercialization ... , Ph.D., Chief Executive Officer, is scheduled to present ... 1, 2015 at 10:50 a.m. EST, at The Lotte ... City . . ...
Breaking Biology Technology:
(Date:10/29/2015)... October 29, 2015 NXTD ... company focused on the growing mobile commerce market ... that StackCommerce, a leading marketplace to discover and ... Wocket® smart wallet on StackSocial for this holiday ... or the "Company"), a biometric authentication company focused ...
(Date:10/27/2015)... 2015 In the present market scenario, security ... various industry verticals such as banking, healthcare, defense, electronic ... demand for secure & simplified access control and growing ... hacking of bank accounts, misuse of users, , and ... PC,s, laptops, and smartphones are expected to provide potential ...
(Date:10/27/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... has adopted the Synaptics ® ClearPad ® ... its newest flagship smartphones, the Nexus 5X by LG ... --> --> Synaptics works closely ... collaboration in the joint development of next generation technologies. ...
Breaking Biology News(10 mins):